Bernard L. Zidar

782 total citations
22 papers, 632 citations indexed

About

Bernard L. Zidar is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bernard L. Zidar has authored 22 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Bernard L. Zidar's work include Occupational and environmental lung diseases (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Bernard L. Zidar is often cited by papers focused on Occupational and environmental lung diseases (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). Bernard L. Zidar collaborates with scholars based in United States and United Kingdom. Bernard L. Zidar's co-authors include Alan Winkelstein, Richard K. Shadduck, Zella R. Zeigler, Stanley P. Balcerzak, H. Irving Pierce, David Friedland, Rachel Miller, M Keating, R. Gluckman and BC Lembersky and has published in prestigious journals such as New England Journal of Medicine, Cancer and The American Journal of Medicine.

In The Last Decade

Bernard L. Zidar

22 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard L. Zidar United States 15 345 170 80 75 66 22 632
D Venzon United States 7 149 0.4× 325 1.9× 53 0.7× 82 1.1× 21 0.3× 7 725
NKC Ramsay United States 11 110 0.3× 247 1.5× 239 3.0× 62 0.8× 50 0.8× 11 630
Michiaki Hirayama Japan 14 139 0.4× 169 1.0× 123 1.5× 92 1.2× 51 0.8× 56 575
Sheryl R. Simon United States 11 86 0.2× 64 0.4× 166 2.1× 46 0.6× 34 0.5× 15 462
Kjell A. Grøttum Norway 12 140 0.4× 77 0.5× 257 3.2× 90 1.2× 14 0.2× 21 541
Hideo Takamatsu Japan 18 382 1.1× 246 1.4× 44 0.6× 218 2.9× 52 0.8× 74 1.1k
Elena Del Ferro Italy 14 102 0.3× 277 1.6× 153 1.9× 83 1.1× 13 0.2× 22 794
Mazen Arar United States 14 124 0.4× 198 1.2× 35 0.4× 388 5.2× 122 1.8× 25 923
Deng F. Liau United States 10 204 0.6× 315 1.9× 253 3.2× 231 3.1× 30 0.5× 12 648
Ketki Tendulkar United States 13 265 0.8× 345 2.0× 65 0.8× 167 2.2× 11 0.2× 22 645

Countries citing papers authored by Bernard L. Zidar

Since Specialization
Citations

This map shows the geographic impact of Bernard L. Zidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard L. Zidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard L. Zidar more than expected).

Fields of papers citing papers by Bernard L. Zidar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard L. Zidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard L. Zidar. The network helps show where Bernard L. Zidar may publish in the future.

Co-authorship network of co-authors of Bernard L. Zidar

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard L. Zidar. A scholar is included among the top collaborators of Bernard L. Zidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard L. Zidar. Bernard L. Zidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedland, David, Jonathan E. Cohen, Rachel Miller, et al.. (1999). A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2.. PubMed. 26(5 Suppl 17). 19–23. 126 indexed citations
2.
Spiridonidis, C. Harris, et al.. (1995). Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictor. Cancer. 75(7). 1586–1593. 9 indexed citations
3.
Zidar, Bernard L.. (1995). Periorbital Edema in Kaposi's Sarcoma. New England Journal of Medicine. 332(18). 1204–1204. 5 indexed citations
4.
Zidar, Bernard L., et al.. (1992). A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study. Cancer. 70(10). 2547–2551. 34 indexed citations
5.
Zidar, Bernard L., et al.. (1992). Mucin-positive epithelial mesothelioma.. PubMed. 116(8). 874–80. 31 indexed citations
6.
Shackney, Stanley E., Reginald P. Pugh, Bernard L. Zidar, et al.. (1990). ViVACCy—A Drug Schedule Based on G2 Blockade and Prolonged Infusion of Multiple Tubulin-Binding Agents A Pilot Study. Cancer. 66(3). 411–417. 1 indexed citations
7.
Zidar, Bernard L., et al.. (1990). Clinical and pathologic features of primary gastric rhabdomyosarcoma. Cancer. 66(4). 772–778. 20 indexed citations
8.
Romano, Thomas J., et al.. (1990). Normal pressure hydrocephalus in a patient with systemic lupus erythematosus.. PubMed. 17(12). 1689–91. 9 indexed citations
9.
Simon, Sheryl R., et al.. (1989). Hematologic Complications of Gastric Bypass for Morbid Obesity. Southern Medical Journal. 82(9). 1108–1110. 19 indexed citations
10.
Zidar, Bernard L., et al.. (1988). A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study. Investigational New Drugs. 6(3). 223–226. 70 indexed citations
11.
Zidar, Bernard L., George J. Magovern, Robert N. Raju, et al.. (1987). Radiation-induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome. Cancer. 60(6). 1238–1242. 18 indexed citations
12.
Zidar, Bernard L., Robert J. Hartsock, Robert Lee, et al.. (1987). Pseudo-Gaucher Cells in the Bone Marrow of a Patient with Hodgkin’s Disease. American Journal of Clinical Pathology. 87(4). 533–536. 31 indexed citations
13.
Mangan, Kenneth F., Bernard L. Zidar, Richard K. Shadduck, Zella R. Zeigler, & Alan Winkelstein. (1985). Interferon‐induced aplasia: Evidence for t‐cell‐mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin. American Journal of Hematology. 19(4). 401–413. 29 indexed citations
14.
Zidar, Bernard L., Robert S. Benjamin, Jess Frank, Montague Lane, & Laurence H. Baker. (1983). Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.. PubMed. 6(1). 71–4. 15 indexed citations
15.
Zidar, Bernard L., et al.. (1983). Treatment of six cases of mesothelioma with doxorubicin and cisplatin. Cancer. 52(10). 1788–1791. 33 indexed citations
16.
Zidar, Bernard L., Robert S. Benjamin, Jess Frank, Montague Lane, & Laurence H. Baker. (1983). Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC:. American Journal of Clinical Oncology. 6(1). 71–73. 13 indexed citations
17.
Zidar, Bernard L., Alan Winkelstein, Theresa L. Whiteside, et al.. (1977). Hairy Cell Leukaemia: Seven Cases with Probable B‐Lymphocytic Origin. British Journal of Haematology. 37(4). 455–465. 23 indexed citations
18.
Smith, William I., Bernard L. Zidar, Alan Winkelstein, et al.. (1977). Hairy Cell Leukemia: A Case with B-lymphocyte Origin. American Journal of Clinical Pathology. 68(6). 778–786. 10 indexed citations
19.
Zidar, Bernard L., Richard K. Shadduck, Alan Winkelstein, Zella R. Zeigler, & Charles D. Hawker. (1976). Acute Myeloblastic Leukemia and Hypercalcemia. New England Journal of Medicine. 295(13). 692–694. 31 indexed citations
20.
Zidar, Bernard L., Harvey Mendelow, Alan Winkelstein, & Richard K. Shadduck. (1975). Diphenylhydantoin-induced serum sickness with fibrin-platelet thrombi in lymph node microvasculature. The American Journal of Medicine. 58(5). 704–708. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Venzon Breakdown of academic impact, for papers by NKC Ramsay Breakdown of academic impact, for papers by Michiaki Hirayama Breakdown of academic impact, for papers by Sheryl R. Simon Breakdown of academic impact, for papers by Kjell A. Grøttum Breakdown of academic impact, for papers by Hideo Takamatsu Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Mazen Arar Breakdown of academic impact, for papers by Deng F. Liau Breakdown of academic impact, for papers by Ketki Tendulkar
Rankless by CCL
2026